Informações:
Falhas:
ID
38133
Descrição
Cisplatin + RT for Triple Negative Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01674842
Link
https://clinicaltrials.gov/show/NCT01674842
Palavras-chave
Versões (1)
- 21/09/2019 21/09/2019 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
21 de setembro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Breast Cancer NCT01674842
Eligibility Breast Cancer NCT01674842
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT01674842
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Primary tumor | Triple Negative Breast Neoplasm
Item
primary tumor is triple negative breast cancer
boolean
C0677930 (UMLS CUI [1])
C3539878 (UMLS CUI [2])
C3539878 (UMLS CUI [2])
Breast-Conserving Surgery | Mastectomy | Excision Disease Gross | Negative Surgical Margin
Item
breast-conserving surgery or mastectomy with surgical excision of all gross disease with negative surgical margins
boolean
C0917927 (UMLS CUI [1])
C0024881 (UMLS CUI [2])
C0728940 (UMLS CUI [3,1])
C0012634 (UMLS CUI [3,2])
C0439806 (UMLS CUI [3,3])
C1709157 (UMLS CUI [4])
C0024881 (UMLS CUI [2])
C0728940 (UMLS CUI [3,1])
C0012634 (UMLS CUI [3,2])
C0439806 (UMLS CUI [3,3])
C1709157 (UMLS CUI [4])
Disease Pathologic TNM stage | Disease TNM Breast tumor staging
Item
pathologic or clinical stage ii or iii disease
boolean
C0012634 (UMLS CUI [1,1])
C1319019 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0474926 (UMLS CUI [2,2])
C1319019 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0474926 (UMLS CUI [2,2])
Interval | Chemotherapy | Operation on breast | Therapeutic radiology procedure
Item
at least 3 week interval from last chemotherapy administration/breast surgery to radiation (no more than 8 weeks)
boolean
C1272706 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
C3714726 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
C0392920 (UMLS CUI [2])
C3714726 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
Pregnancy | Breast Feeding
Item
pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Irradiation of breast Previous | Irradiation of lymph nodes regional ipsilateral previous
Item
prior radiation to breast or ipsilateral regional nodes
boolean
C2148528 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C2169077 (UMLS CUI [2,1])
C0205147 (UMLS CUI [2,2])
C0441989 (UMLS CUI [2,3])
C0205156 (UMLS CUI [2,4])
C0205156 (UMLS CUI [1,2])
C2169077 (UMLS CUI [2,1])
C0205147 (UMLS CUI [2,2])
C0441989 (UMLS CUI [2,3])
C0205156 (UMLS CUI [2,4])
Investigational New Drugs
Item
ongoing therapy with other investigational agents
boolean
C0013230 (UMLS CUI [1])
Hormone Therapy
Item
hormonal therapy
boolean
C0279025 (UMLS CUI [1])
Comorbidity Significant
Item
significant co-morbidity
boolean
C0009488 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
C0750502 (UMLS CUI [1,2])
Pathologic Complete Response Following Preoperative Chemotherapy
Item
pathologic complete response following preoperative chemotherapy
boolean
C4050242 (UMLS CUI [1,1])
C0332282 (UMLS CUI [1,2])
C2347669 (UMLS CUI [1,3])
C0332282 (UMLS CUI [1,2])
C2347669 (UMLS CUI [1,3])
Neoplasm Metastasis
Item
biopsy proven metastatic disease
boolean
C0027627 (UMLS CUI [1])